Neogen Corporation (NEOG) — Form 10-Q Summary
Reporting period: Quarter and six months ended November 30, 2023 (Neogen fiscal 2024 second quarter). Unaudited results. Neogen develops and sells food-safety and animal-safety products and services. Comparisons are affected by the September 2022 combination with 3M’s Food Safety Division (FSD), which is included for a longer period in the current six-month results than in the prior-year comparison.
Key financial results
| Metric | Three months ended Nov. 30 | Six months ended Nov. 30 |
|---|---|---|
| Revenue | $229.6 million, versus $230.0 million (approximately flat) | $458.6 million, versus $362.4 million (+27%) |
| Gross profit and margin | $116.8 million; 50.9%, versus 48.9% | $233.5 million; 50.9%, versus 48.2% |
| Operating income (loss) | $14.5 million, versus $(7.7) million | $33.6 million, versus $(1.6) million |
| Net loss and diluted loss per share | $(3.5) million; $(0.02), versus $(41.8) million; $(0.19) | $(2.0) million; $(0.01), versus $(36.6) million; $(0.23) |
| Operating cash flow | Not separately presented for the quarter | $38.7 million, versus $(32.9) million |
Revenue and segments: Second-quarter Food Safety revenue rose 2% to $164.4 million, while Animal Safety revenue declined 5% to $65.2 million. Management reported core sales growth of 1% for Food Safety and a 5% decline for Animal Safety in the quarter; consolidated core sales declined 1%. For the six-month period, Food Safety revenue increased 46% and Animal Safety declined 6%, with the reported consolidated increase substantially reflecting the FSD comparison. Service revenue fell to $25.8 million for the quarter and $50.3 million for six months, mainly due to attrition of a large domestic poultry customer as the company shifted its genomics focus toward larger production animals.
Expenses and adjusted results: Second-quarter operating expenses were $102.3 million, down from $120.2 million, primarily reflecting lower transaction and integration costs. Six-month operating expenses increased to $199.9 million from $176.4 million, including a longer period of FSD-related operating costs and acquired-intangible amortization. Interest expense was $18.0 million for the quarter and $36.5 million for six months. Non-GAAP adjusted EBITDA was $55.1 million for the quarter (24.0% margin), versus $64.1 million (27.8%); for six months it was $107.5 million (23.4%), versus $91.1 million (25.1%). Adjusted net income was $24.9 million for the quarter and $48.6 million for six months; these are non-GAAP measures and include adjustments such as acquired-intangible amortization and transaction-related costs.
Financial position and liquidity
- At November 30, cash and cash equivalents were $205.8 million and marketable securities were $24.5 million, totaling $230.3 million, down from $245.6 million at May 31, 2023.
- Current assets were $624.4 million and current liabilities $176.6 million. The filing reports no drawn balance on the $150 million revolving credit facility.
- Debt consisted of a $550 million term loan and $350 million of senior notes, plus a $2.6 million finance lease. The notes bear 8.625% interest and mature in 2030; term-loan rates ranged from 7.42% to 7.67% during the six months. A $250 million interest-rate swap fixes the benchmark rate on part of the term loan. The company reported covenant compliance.
- Six-month investing cash flow was $2.9 million, including $55.0 million of property, equipment and other non-current intangible purchases, largely offset by marketable-security maturities. Management expects approximately $130 million of fiscal 2024 capital expenditures, including about $100 million for a new building, systems implementation and food-safety integration projects.
- Inventory increased $26.7 million from May 31 to $160.5 million, primarily as Neogen began stocking FSD products. Management expected to spend approximately $40–$50 million to initially stock FSD inventory globally in fiscal 2024.
Changes, outlook, risks and contingencies
- Management provided no forecast of future financial performance. It expects inflationary effects to continue during fiscal 2024, though at a decreasing rate, and cited softening consumer demand, high interest rates and geopolitical tensions. Higher rates increase costs on the unhedged portion of the variable-rate term loan.
- The transition manufacturing, invoicing and distribution arrangements with 3M are being exited; distribution-related services were expected to end globally by the end of fiscal Q3 2024. Management cited European food-safety supply challenges partly related to the transition. A net receivable from 3M was $25.3 million at November 30, up from $12.4 million at May 31.
- Management said operating cash flows, cash on hand and borrowing capacity are expected to support operations, debt service, planned construction and strategic plans, while noting that future cash generation and borrowing capacity may not be sufficient for all potential needs.
- Integration costs and professional fees related to the FSD transaction were $4.6 million in the quarter and $6.2 million for six months. Acquired-intangible amortization was $23.7 million for the quarter and $47.4 million for six months. The FSD business contributed $99.8 million of second-quarter revenue and approximately $12 million of operating income, including integration costs and acquired-intangible amortization.
- The company recorded a $0.9 million estimated liability for environmental remediation at its Randolph, Wisconsin facility. The outcome of a pilot study and discussions about potential alternative remediation strategies is uncertain and could increase future costs. Management said ordinary-course legal proceedings were not expected to have a material effect.
- Disclosure controls were judged ineffective because of previously reported material weaknesses involving IT general controls, period-end invoice accruals, and management review of acquisition accounting, valuation and goodwill. Remediation is ongoing and the weaknesses were not yet considered remediated. The filing reported no material changes to the risk factors in the prior Form 10-K.
Most important facts for investors to verify
- Whether underlying core sales and Animal Safety performance improve, apart from acquisition-driven reported growth.
- Progress and costs of the 3M transition-services exit, FSD integration, inventory build and planned capital projects.
- Cash conversion and working-capital trends, particularly inventory growth and receivables billed by 3M.
- Interest expense, variable-rate exposure, covenant headroom and the company’s ability to fund planned investment while servicing approximately $900 million of principal debt.
- Remediation of the disclosed internal-control material weaknesses, and any changes in environmental-remediation estimates.